Psyence Biomedical (PBM) Free Cash Flow (2023)
Psyence Biomedical (PBM) recorded quarterly Free Cash Flow of -$1.6 million in Q1 2023.
Psyence Biomedical (PBM) Free Cash Flow (2023) Analysis & Trends
Psyence Biomedical's Free Cash Flow history runs 1 years deep, the most recent figure standing at -$1.6 million for Q1 2023.
- In Q1 2023, Free Cash Flow changed N/A year-over-year to -$1.6 million; the TTM figure through Mar 2025 stood at -$1.6 million (changed N/A YoY), while the FY2025 annual figure was -$9877.0, up 99.66% from the prior year.
- Free Cash Flow was -$1.6 million for Q1 2023 at Psyence Biomedical.
- In the past five years, Free Cash Flow ranged from a high of -$1.6 million in Q1 2023 to a low of -$1.6 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | -2.49 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.29 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 63,220.27 |
| 10 | Regeneron Pharmaceuticals | 66.09 Bn | 57.33 Bn | 3.31 Bn | 848.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -1.59 Mn |
| Mar 31, 2023 | -1.59 Mn |